Literature DB >> 29300210

Pediatric Brain: Gadolinium Deposition in Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images Is Dependent on the Type of Contrast Agent.

Young Jin Ryu, Young Hun Choi, Jung-Eun Cheon, Woo-Jin Lee, Subin Park, Ji Eun Park, Woo Sun Kim, In-One Kim.   

Abstract

PURPOSE: The aim of this study was to identify the signal intensity (SI) changes in the dentate nucleus (DN) and the globus pallidus (GP) on unenhanced T1-weighted magnetic resonance (MR) images after multiple administration of gadolinium-based contrast agents (GBCAs) in children and compare those changes between linear and macrocyclic GBCAs.
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board and the requirement for informed consent was waived. We identified 92 children who underwent at least 4 consecutive MR examinations exclusively using either linear GBCA (gadodiamide or gadopentetate dimeglumine, n = 41) or macrocyclic GBCA (gadoterate meglumine, n = 51). Signal intensity ratio changes in the DN to pons and GP to thalamus between the first and last MR examinations were calculated.
RESULTS: The SI ratios in the linear group increased significantly between the first and last MR examinations (mean difference: DN to pons, 0.0461 ± 0.0480, P < 0.001; GP to thalamus, 0.0332 ± 0.0385, P < 0.001), but not in the macrocyclic group (mean difference: DN to pons, -0.0010 ± 0.0371, P = 0.855; GP to thalamus, 0.0007 ± 0.0294, P = 0.867). In the linear regression analysis, the numbers of administrations of gadodiamide and gadopentetate dimeglumine were highly associated with the differences in SI ratios (DN to pons, P < 0.001 and P = 0.003; GP to thalamus, P < 0.001 and P = 0.002, respectively).
CONCLUSION: The SIs of the DN and GP on unenhanced T1-weighted images increased after serial administrations of linear GBCA, but not macrocyclic GBCA, in children. The number of linear GBCA administration had a linear association with the SI changes in the DN and GP.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29300210     DOI: 10.1097/RLI.0000000000000436

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  13 in total

Review 1.  Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.

Authors:  Carlo C Quattrocchi; Joana Ramalho; Aart J van der Molen; Àlex Rovira; Alexander Radbruch
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

Review 2.  Gadolinium retention - 5 years later….

Authors:  Jonathan R Dillman; Matthew S Davenport
Journal:  Pediatr Radiol       Date:  2020-01-23

3.  3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.

Authors:  Huimin Hou; Weibo Chen; Yanzhao Diao; Yuhan Wang; Li Zhang; Liming Wang; Min Xu; Jinchao Yu; Tao Song; Yu Liu; Zhenguo Yuan
Journal:  Mol Imaging Biol       Date:  2022-08-12       Impact factor: 3.484

4.  Diffusion Tensor Imaging of the Dentate Nucleus After Repeated Administration of Gadobutrol in Children.

Authors:  Kerem Ozturk; David Nascene
Journal:  Cerebellum       Date:  2021-08-27       Impact factor: 3.648

Review 5.  Contrast-enhanced ultrasound of liver lesions in children.

Authors:  Alexander M El-Ali; James C Davis; Jennifer M Cickelli; Judy H Squires
Journal:  Pediatr Radiol       Date:  2019-10-16

6.  Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.

Authors:  Jonathan R Young; Joe Qiao; Iren Orosz; Noriko Salamon; Mark A Franke; Hyun J Kim; Whitney B Pope
Journal:  Eur Radiol       Date:  2018-05-09       Impact factor: 5.315

7.  Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.

Authors:  S Dogra; M J Borja; Y W Lui
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-25       Impact factor: 3.825

Review 8.  Gadolinium Deposition in the Brain: Current Updates.

Authors:  Jin Woo Choi; Won-Jin Moon
Journal:  Korean J Radiol       Date:  2018-12-27       Impact factor: 3.500

9.  Undetectable gadolinium brain retention in individuals with an age-dependent blood-brain barrier breakdown in the hippocampus and mild cognitive impairment.

Authors:  Axel Montagne; Mikko T Huuskonen; Gautham Rajagopal; Melanie D Sweeney; Daniel A Nation; Farshid Sepehrband; Lina M D'Orazio; Michael G Harrington; Helena C Chui; Meng Law; Arthur W Toga; Berislav V Zlokovic
Journal:  Alzheimers Dement       Date:  2019-12       Impact factor: 21.566

Review 10.  Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives.

Authors:  Bang J Guo; Zhen L Yang; Long J Zhang
Journal:  Front Mol Neurosci       Date:  2018-09-20       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.